Lot certificates published
Plain, secure packaging

commonly confused

CJC-1295 vs Sermorelin

These records distinguish the substituted non-DAC backbone recorded as CJC-1295 from sermorelin’s GRF(1-29) sequence. The cited CJC report concerns DAC-bearing conjugates; its species must not be conflated with this non-DAC record.

Published: 2026-10-03Library record comparison: 2026-10-15

01

Identity side by side

Recorded molecular identities of CJC-1295 and Sermorelin
Recorded fieldCJC-1295Sermorelin
Canonical nameCJC-1295Sermorelin
AliasesCJC 1295GRF(1-29); Sermorelina; Sermorelinum
Development codesnot recordednot recorded
CASnot recorded86168-78-7
UNIInot recorded89243S03TE
PubChem CID5684194516132413
Molecular formulaC152H252N44O42C149H246N44O42S
Molecular weight (Da)3367.953357.9
Sequence length (residues)2929
Terminal modificationsFree N-terminus; C-terminal amide at Arg29Free N-terminus; C-terminal amide at Arg29
Structural modificationsnot recordednot recorded

CJC-1295: nomenclature notes

The name CJC-1295 is used in the literature and in commerce for two distinct species. The compound identified in the original report is a tetrasubstituted form of hGRF(1-29) bearing an N-epsilon-3-maleimidopropionamide derivative of lysine at the C-terminus; that maleimido group is the drug affinity complex, and it bioconjugates in vivo to the free thiol at Cys34 of serum albumin. Material sold as CJC-1295 without DAC lacks that linker and does not form the albumin conjugate, and is the species this record describes; it is the CJC-1295 component of the catalog's CJC-1295 / ipamorelin blend, while the catalog's CJC-1295 With DAC listing is the other species. PubChem CID 56841945 encodes the non-DAC 29-mer with D-Ala2 and Arg29-amide (C152H252N44O42; 3367.95 Da), whereas CID 91971820 encodes the DAC species (C165H269N47O46; 3647.2 Da; CAS 446262-90-4; UNII 62RC32V9N7); CID 91976842 omits stereochemistry. PubChem CID 91971820, CAS 446262-90-4 and GSRS UNII 62RC32V9N7 identify the DAC form and are excluded from this non-DAC record. No CAS or UNII is published for the non-DAC species because none could be verified against a primary registry. Identity should be established against the intended species, and a supplier certificate quoting 3647.2 Da is describing the other molecule.

Sermorelin: nomenclature notes

Sermorelin corresponds to residues 1 to 29 of human growth hormone-releasing factor, the fragment commonly written GRF(1-29). Two related entries are in this library. CJC-1295 is a tetrasubstituted analog of this fragment; the form bearing an added C-terminal maleimidopropionamide lysine, which enables albumin conjugation, is a separate species from the one the CJC-1295 entry describes. Tesamorelin is not a derivative of the fragment: it is the full 44-residue sequence, of which this fragment is the first 29 residues, carrying an N-terminal hexenoyl group and a C-terminal amide.

02

Residue sequence comparison

Positions are numbered from each stored sequence’s first residue. Highlighted cells differ or extend beyond the other chain; a dash indicates no aligned residue. Three-letter notation marks D-residues but does not encode terminal groups. Read the recorded notes below.

Aligned three-letter residue sequences
CJC-12951Tyr2D-Ala3Asp4Ala5Ile6Phe7Thr8Gln9Ser10Tyr11Arg12Lys13Val14Leu15Ala16Gln17Leu18Ser19Ala20Arg21Lys22Leu23Leu24Gln25Asp26Ile27Leu28Ser29Arg
Sermorelin1Tyr2Ala3Asp4Ala5Ile6Phe7Thr8Asn9Ser10Tyr11Arg12Lys13Val14Leu15Gly16Gln17Leu18Ser19Ala20Arg21Lys22Leu23Leu24Gln25Asp26Ile27Met28Ser29Arg

Differences in the three-letter sequence

  • CJC-1295: residue 2 = D-Ala; Sermorelin: residue 2 = Ala.
  • CJC-1295: residue 8 = Gln; Sermorelin: residue 8 = Asn.
  • CJC-1295: residue 15 = Ala; Sermorelin: residue 15 = Gly.
  • CJC-1295: residue 27 = Leu; Sermorelin: residue 27 = Met.

Further differences are recorded in the sequence notes.

CJC-1295

Terminal modifications
Free N-terminus; C-terminal amide at Arg29
Structural modifications
not recorded
Stored three-letter notation
Tyr · D-Ala · Asp · Ala · Ile · Phe · Thr · Gln · Ser · Tyr · Arg · Lys · Val · Leu · Ala · Gln · Leu · Ser · Ala · Arg · Lys · Leu · Leu · Gln · Asp · Ile · Leu · Ser · Arg
Sequence notes
Twenty-nine residues, the tetrasubstituted hGRF(1-29) analog without the drug affinity complex. Against unmodified GRF(1-29), recorded on the sermorelin entry as YADAIFTNSYRKVLGQLSARKLLQDIMSR, the four changes are D-alanine at position 2, glutamine for asparagine at position 8, alanine for glycine at position 15, and leucine for methionine at position 27. No one-letter string is published here: one-letter symbols denote L residues unless marked, so writing position 2 as A would state the L-alanine of the parent fragment. The D-configuration has the same elemental composition, so the three-letter chain still derives the recorded formula and mass. The substitution at position 27 removes the only sulfur-containing residue of the parent fragment, which is why this record has no sulfur while sermorelin does.

Sermorelin

Terminal modifications
Free N-terminus; C-terminal amide at Arg29
Structural modifications
not recorded
Stored three-letter notation
Tyr · Ala · Asp · Ala · Ile · Phe · Thr · Asn · Ser · Tyr · Arg · Lys · Val · Leu · Gly · Gln · Leu · Ser · Ala · Arg · Lys · Leu · Leu · Gln · Asp · Ile · Met · Ser · Arg
Sequence notes
The N-terminal 29 residues of human growth hormone-releasing hormone, carried as a C-terminal amide. The recorded molecular formula and mass are the values this sequence derives with that amide applied; without it the derivation gives the free acid and does not match. The IUPHAR/BPS Guide to Pharmacology (ligand 6998, release 2026.3.1) prints a thirty-residue sermorelin sequence ending Gln30; this record keeps the twenty-nine-residue fragment ending in Arg29 amide, matching PubChem CID 16132413.

03

Recorded mechanisms

These lists show the links recorded in each monograph. An unlisted link does not establish its absence from the molecule’s biology.

Shared recorded links

Recorded only for CJC-1295

not recorded

Recorded only for Sermorelin

not recorded

04

Recorded compound classes

Shared recorded links

Recorded only for CJC-1295

not recorded

Recorded only for Sermorelin

not recorded

05

References for the relationship

  1. Reference 1

    Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog.

    Jetté L, Léger R, Thibaudeau K, Benquet C, Robitaille M, Pellerin I, Paradis V, van Wyk P, Pham K, Bridon DP

    Endocrinology · 2005-04-07 · Journal Article

    current

Study models of these references

What kind of experiment each cited paper reports, taken from its abstract unless marked. Not a summary of results.

ReferenceStudy models
Jetté L et al. 2005Study models reported: in vitro; animal (rat) · from the abstract

06

Read the full monographs